S. Monti Et Al. , "Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes," Rheumatology (United Kingdom) , vol.60, no.2, pp.617-628, 2021
Monti, S. Et Al. 2021. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes. Rheumatology (United Kingdom) , vol.60, no.2 , 617-628.
Monti, S., Klersy, C., Montecucco, C., Caporali, R., Watts, R., Achilleos, K., ... Adler, M.(2021). Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes. Rheumatology (United Kingdom) , vol.60, no.2, 617-628.
Monti, Sara Et Al. "Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes," Rheumatology (United Kingdom) , vol.60, no.2, 617-628, 2021
Monti, Sara Et Al. "Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes." Rheumatology (United Kingdom) , vol.60, no.2, pp.617-628, 2021
Monti, S. Et Al. (2021) . "Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes." Rheumatology (United Kingdom) , vol.60, no.2, pp.617-628.
@article{article, author={Sara Monti Et Al. }, title={Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes}, journal={Rheumatology (United Kingdom)}, year=2021, pages={617-628} }